Inventor · disambiguated record
Donald Mcleod
Also filed as: MCLEOD DONALD · MCLEOD DONALD A
7 granted patents·17 pending applications·318 citations·filing 1993–2014
87Inventor score
Files withASTRAZENECA AB12NPS PHARMA INC4ALZHEIMER S INST OF AMERICA1ARORA JALAJ1ASTRAZENECA AB AND NPS PHARMAC1
Top patents by PatentIndex Score
24 records- 0198US6660753B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2002·Granted Dec 9, 2003·160 cites·58 claims
- 0296US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 0393US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0487US7960422B2Pharmaceutically active compounds containing tetrazolyl and triazolyl ringsASTRAZENECA AB·Filed 2008·Granted Jun 14, 2011·11 cites·2 claims
- 0582US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 0662US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0762US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0862US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0962US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1057US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 1152US2008312246A1Substituted Piperazines as Metabotropic Glutamate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1252US2007037820A1Substituted piperazines as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 1349US7691892B2Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Apr 6, 2010·0 cites·22 claims
- 1449US2015352108A1Amino-pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilonALZHEIMER S INST OF AMERICA·Filed 2014·Application pending·0 cites
- 1548US2006063772A1New compoundsARORA JALAJ·Filed 2005·Application pending·0 cites
- 1648US2007197549A1Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1748US2007255061A15-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5ASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1847US2004132726A1New compoundsASTRAZENECA AB AND NPS PHARMAC·Filed 2003·Application pending·0 cites
- 1945US2004152699A1CompoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2003·Application pending·0 cites
- 2045US2006189661A1Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsWAGENEN BRADFORD V·Filed 2006·Application pending·0 cites
- 2144US2012238540A1Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1HOLCOMB RYAN C·Filed 2012·Application pending·0 cites
- 2241US5599912ACompounds and methods for suppressing an immune response to sulfomethoxozale containing substancesCORETECH INC·Filed 1993·Granted Feb 4, 1997·10 cites·7 claims
- 2340US2007185095A1Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2436US2014288044A1Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitorsHOLCOMB RYAN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald Mcleod files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →